🇺🇸 FDA
Patent

US 11235076

Chelating platform for delivery of radionuclides

granted A61KA61K51/0478A61K51/0482

Quick answer

US patent 11235076 (Chelating platform for delivery of radionuclides) held by The Regents of the University of California expires Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Feb 01 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 27 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
21
CPC classes
A61K, A61K51/0478, A61K51/0482, A61P, A61P35/00